Insulin Pump

Origin

Korea

Insulin Pump for diabetes – Willcare

Description

WILLCARE of Unitma, is an insulin pump made with the combination of the best electromechanical technology and medical expertise in Korea. WILLCARE is a small and programmable medical device used for the administration of insulin also known as CSII (continuous subcutaneous insulin infusion) therapy in the treatment of Diabetes.
WILLCARE is an alternative to multiple daily injections of insulin by insulin syringe pen and allows for intensive insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.

Use of WILLCARE is increasing worldwide because of :

1. Extremely light weight 49g and world smallest size insulin pump.
2. Reservoir capacity is 300U and basal insulin is delivered in every 3 minutes which enables the effective blood glucose control between meals. Therefore, it is possible to keep sound blood glucose curve.
3. High Insulin absorption ratio because the pump is designed to deliver Bolus Insulin 1 unit slowly for 20seconds.
4. The interface of operation is programmed for simple and easy use, so it is very convenient and easy to use for most people who have diabetes.
5. High reliability of operation.
6. Unitma Co., Ltd wishes to be a practical help to world Diabetes patients by supplying affordable price but excellent quality products.